Regulus Therapeutics Inc. (38) | Uncategorized (8)
Recent Contracts
-
Joseph P. Hagan, Yearly Discretionary Base Salary Increase, effective January 1, 2022
(Filed With SEC on March 11, 2022)
-
Christopher Aker, Yearly Discretionary Base Salary Increase, effective January 1, 2022
(Filed With SEC on March 11, 2022)
-
Cris Calsada, Yearly Discretionary Base Salary Increase, effective January 1, 2022
(Filed With SEC on March 11, 2022)
-
Denis Drygin, Yearly Discretionary Base Salary Increase, effective January 1, 2022
(Filed With SEC on March 11, 2022)
-
Joseph P. Hagan, Yearly Discretionary Base Salary Increase, effective January 1, 2019
(Filed With SEC on March 9, 2021)
-
Joseph P. Hagan, Yearly Discretionary Base Salary Increase, effective January 1, 2020
(Filed With SEC on March 9, 2021)
-
Offer Letter Agreement, dated July 29, 2019, by and between the Company and Cris Calsada
(Filed With SEC on July 30, 2019)
-
Agreement, dated February 19, 2019, by and between the Registrant and Nitto Biopharma, Inc
(Filed With SEC on March 18, 2019)